Ocular adverse events associated with antibody-drug conjugates used in cancer: Focus on pathophysiology and management strategies
Éric Gabison, Antoine Rousseau, M. Labetoulle, Anas Gazzah, Benjamin Besse
Topics & Concepts
MedicineAdverse effectPathophysiologyAntibody-drug conjugateDrugCancerPharmacologyAntibodyIntensive care medicineImmunologyInternal medicineMonoclonal antibodyChronic Lymphocytic Leukemia ResearchHER2/EGFR in Cancer ResearchAdvanced Breast Cancer Therapies